In response to the Trump Administration’s revised executive order on immigration, signed on March 6, ASH President Kenneth C. Anderson, MD, released the following statement, which reiterates concerns about the order’s potential impact on research:
“ASH remains concerned that the disruption and uncertainty in issuing and renewing visas could hurt patient care and scientific research in the United States by barring or dissuading talented physicians, researchers, and other individuals from coming to or remaining in our country. We reiterate the concerns outlined in our joint statement on the previous executive order and respectfully call on the White House to balance its duty to protect our borders with ensuring the United States attracts the strongest possible biomedical research workforce, which includes immigrants.”
ASH previously released a joint statement with the American Association for Cancer Research, the Association of American Cancer Institutes, the American Society for Radiation Oncology, the American Society of Pediatric Hematology/Oncology, and the LUNGevity Foundation expressing concerns about the earlier executive order on immigration signed on January 27. These concerns included the potential loss of collaboration with international colleagues. In the statement, ASH and its peers remind President Donald Trump’s administration that progress in cancer research is global and “for this progress to continue, it is going to require an even greater commitment to collaborations among international organizations, governments, public and private institutions, and individuals dedicated to this cause.”
Source: American Society of Hematology news release, March 7, 2017.